Sullivan John F

SEC source: 0000899243-21-034767 · doc4.xml · derivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,772

Underlying: Common Stock · 3,200 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-21-034767 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,273

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.

SEC source: 0000899243-21-015506 · doc4.xml · derivative · entry 7

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,437

Underlying: Common Stock · 12,000 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.

SEC source: 0000899243-21-015506 · doc4.xml · derivative · entry 6

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 3,000 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

SEC source: 0000899243-21-015506 · doc4.xml · nonDerivative · entry 5

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $37.20 to $37.75 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-015506 · doc4.xml · nonDerivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,777

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $36.20 to $37.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-015506 · doc4.xml · nonDerivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,761

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.20 to $35.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-015506 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-21-015506 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-21-008450 · doc4.xml · derivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-02-24

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

SEC source: 0000899243-21-005847 · doc4.xml · derivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,600 shares

Expires 2023-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,028

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.41 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-005847 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-21-002615 · doc4.xml · derivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 9,617 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $21.99 to $22.55 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-002615 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-20-034833 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.66 to $18.35 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 5

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,617

Underlying: Common Stock · 1,000 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-034318 · doc4.xml · derivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,617

Underlying: Common Stock · 3,000 shares

Expires 2021-09-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $16.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-20-034318 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0000899243-20-007517 · doc4.xml · derivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-02-27

F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

SEC source: 0000899243-19-027523 · doc4.xml · derivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

Underlying: Common Stock · 1,400 shares

Expires 2023-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-027523 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 12

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,437

Underlying: Common Stock · 24,437 shares

Expires 2027-06-22

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 11

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,437 shares

Expires 2027-06-22

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 10

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,972

Underlying: Common Stock · 18,972 shares

Expires 2023-05-29

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 9

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,972 shares

Expires 2023-05-29

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 8

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2023-03-27

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 7

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2023-03-27

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 6

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,617

Underlying: Common Stock · 14,617 shares

Expires 2021-09-27

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 5

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,617 shares

Expires 2021-09-27

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 4

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285

Underlying: Common Stock · 285 shares

Expires 2020-12-16

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · derivative · entry 3

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 285 shares

Expires 2020-12-16

F2 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F2 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.

F3 · derivative.exercise_date: The option is fully vested.

SEC source: 0000899243-19-012302 · doc4.xml · nonDerivative · entry 2

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,428

F1 · kind: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis.

F1 · price: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis.

SEC source: 0000899243-19-012302 · doc4.xml · nonDerivative · entry 1

Sullivan John F · CIK 0001774273 · VP of Quality & Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis.

F1 · price: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis.